Subversion of interleukin-1-mediated host defence by a nasal carrier strain of Staphylococcus aureus

Immunology. 2009 Sep;128(1 Suppl):e222-9. doi: 10.1111/j.1365-2567.2008.02952.x. Epub 2008 Oct 15.

Abstract

Staphylococcus aureus, a major source of nosocomial and community-acquired infections, has a nasal carriage rate exceeding 25% in the human population. To elucidate host-pathogen interactions pertaining to nasal carriage, we examined the role of interleukin-1 (IL-1) in the colonization of human nasal epithelial cells (NEC) by a nasal carrier strain and a non-carrier strain of S. aureus. Using an organotypic model of the nasal epithelium, we observed that inoculation with a non-carrier strain of S. aureus induced production of IL-1 from NEC, but the expression of this cytokine was significantly reduced when NEC were inoculated with a carrier strain. Moreover, both IL-1alpha and IL-1beta significantly decreased the growth of the nasal carrier strain of S. aureus (P < 0.001, n = 17 to n = 25); however the growth of the non-carrier strain was unaffected. Interestingly, it was found that several nasal carrier strains of S. aureus form quorum-dependent biofilms, which can be partially inhibited when preincubated with IL-1alpha. Taken together these data suggest that, although nasal carrier strains of S. aureus are sensitive to IL-1, they display a significant colonization advantage by both preventing the host from expressing IL-1 and elaborating a protective biofilm.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biofilms / drug effects
  • Biofilms / growth & development
  • Carrier State / immunology*
  • Cell Line
  • Host-Pathogen Interactions / drug effects
  • Host-Pathogen Interactions / immunology
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / immunology
  • Interleukin 1 Receptor Antagonist Protein / pharmacology
  • Interleukin-10 / immunology
  • Interleukin-10 / pharmacology
  • Interleukin-1alpha / immunology*
  • Interleukin-1alpha / pharmacology
  • Interleukin-1beta / immunology*
  • Interleukin-1beta / pharmacology
  • Nasal Mucosa / immunology*
  • Nasal Mucosa / microbiology
  • Staphylococcal Infections / immunology*
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / immunology*
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • IL10 protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1alpha
  • Interleukin-1beta
  • Tumor Necrosis Factor-alpha
  • Interleukin-10